PTKFF saw its Momentum Indicator move above the 0 level on November 26, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned positive. In of the 74 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for PTKFF just turned positive on December 04, 2024. Looking at past instances where PTKFF's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for PTKFF crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for PTKFF entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.550) is normal, around the industry mean (5.632). P/E Ratio (28.490) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.018) settles around the average of (0.164) among similar stocks. P/S Ratio (3.251) is also within normal values, averaging (3.643).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTKFF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTKFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Industry PharmaceuticalsMajor
A.I.dvisor tells us that PTKFF and SNPHF have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFF and SNPHF's prices will move in lockstep.
Ticker / NAME | Correlation To PTKFF | 1D Price Change % | ||
---|---|---|---|---|
PTKFF | 100% | N/A | ||
SNPHF - PTKFF | 2% Poorly correlated | N/A | ||
OTSKY - PTKFF | 1% Poorly correlated | +0.96% | ||
OTSKF - PTKFF | 0% Poorly correlated | N/A | ||
RCDTF - PTKFF | 0% Poorly correlated | N/A | ||
SNPHY - PTKFF | -0% Poorly correlated | -2.02% | ||
More |